CHMA Quote, Trading Chart, Chiasma Inc.
home / stock / chma / chma quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-02 | 4.06 | 3.99 | 4.11 | 3.96 | 1,163,553 |
| 2021-03-01 | 3.94 | 3.95 | 4 | 3.88 | 801,805 |
| 2021-02-26 | 3.91 | 3.89 | 3.93 | 3.68 | 1,423,245 |
| 2021-02-25 | 3.96 | 3.85 | 4.02 | 3.775 | 1,497,918 |
| 2021-02-24 | 3.95 | 3.96 | 4.11 | 3.93 | 1,296,750 |
| 2021-02-23 | 4.01 | 3.91 | 4.0102 | 3.8 | 2,195,356 |
| 2021-02-22 | 4.29 | 4.06 | 4.31 | 4.03 | 1,562,906 |
| 2021-02-19 | 4.24 | 4.2 | 4.27 | 4.16 | 1,132,982 |
| 2021-02-18 | 4.32 | 4.23 | 4.3201 | 4.2 | 950,546 |
| 2021-02-17 | 4.25 | 4.31 | 4.35 | 4.16 | 1,174,560 |
| 2021-02-16 | 4.32 | 4.26 | 4.45 | 4.18 | 1,099,056 |
| 2021-02-15 | 4.33 | 4.33 | 4.46 | 4.22 | 875,900 |
| 2021-02-12 | 4.33 | 4.33 | 4.46 | 4.22 | 871,672 |
| 2021-02-11 | 4.45 | 4.37 | 4.52 | 4.23 | 1,581,386 |
| 2021-02-10 | 4.6 | 4.47 | 4.63 | 4.31 | 1,757,718 |
| 2021-02-09 | 5 | 4.55 | 5 | 4.53 | 1,724,471 |
| 2021-02-08 | 4.4653 | 4.89 | 4.91 | 4.4653 | 1,796,645 |
| 2021-02-05 | 4.25 | 4.355 | 4.49 | 4.153 | 1,235,403 |
| 2021-02-04 | 4.14 | 4.24 | 4.31 | 4.08 | 1,153,594 |
| 2021-02-03 | 4.04 | 4.07 | 4.11 | 4 | 1,257,027 |
News, Short Squeeze, Breakout and More Instantly...
-
NEEDHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company, today announced that management will present a company overview at the H.C. Wainwright Global Life Sciences Conference, which is being held Tuesday, March 9 th ...
-
NEEDHAM, Maine, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, today announced that it will host a conference call and live audio webcast on Thursday, March 4, 2021 at 5:00 pm Eastern Time to discuss financial results for the qu...
-
NEEDHAM, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases currently treated with burd...